Gene · 8846
Papers2,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment. | Cancers (Basel) | 2023 | 37190171 | PubTator, text mining | PubMed |
| A case report on para-Bombay blood group. | Asian J Transfus Sci | 2023 | 37188034 | PubTator, text mining | PubMed |
| ABO incompatibility: A cause for neonatal alloimmune thrombocytopenia. | Asian J Transfus Sci | 2023 | 37188011 | PubTator, text mining | PubMed |
| Histone Demethylation Profiles in Nonalcoholic Fatty Liver Disease and Prognostic Values in Hepatocellular Carcinoma: A Bioinformatic Analysis. | Curr Issues Mol Biol | 2023 | 37185761 | PubTator, text mining | PubMed |
| Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. | Breast Cancer | 2023 | 37178414 | PubTator, text mining | PubMed |
| Genomic insights into cryptic cycles of microbial hydrocarbon production and degradation in contiguous freshwater and marine microbiomes. | Microbiome | 2023 | 37173775 | PubTator, text mining | PubMed |
| Xiao Chai Hu Tang alleviates the pancreatic tumorigenesis via improving the mtDNA N6-Methyladenine modification mediated mitochondrial dysfunction in Syrian hamster model. | Phytomedicine | 2023 | 37172477 | PubTator, text mining | PubMed |
| The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37170222 | PubTator, text mining | PubMed |
| Overview of distinct 5-methylcytosine profiles of messenger RNA in normal and knock-down NSUN2 colorectal cancer cells. | Front Genet | 2023 | 37168511 | PubTator, text mining | PubMed |
| Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies. | Discov Oncol | 2023 | 37155024 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex. | Biochim Biophys Acta Gene Regul Mech | 2023 | 37146713 | PubTator, text mining | PubMed |
| A comprehensive genomic analysis provides insights on the high environmental adaptability of Acinetobacter strains. | Front Microbiol | 2023 | 37138596 | PubTator, text mining | PubMed |
| Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure. | Environ Toxicol Pharmacol | 2023 | 37137421 | PubTator, text mining | PubMed |
| Vibrio MARTX toxin processing and degradation of cellular Rab GTPases by the cytotoxic effector Makes Caterpillars Floppy. | bioRxiv | 2023 | 37131655 | PubTator, text mining | PubMed |
| Research Progress of m6A RNA Methylation in Skin Diseases. | Biomed Res Int | 2023 | 37124930 | PubTator, text mining | PubMed |
| Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids. | Front Bioeng Biotechnol | 2023 | 37122849 | PubTator, text mining | PubMed |
| Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. | J Clin Invest | 2023 | 37104042 | PubTator, text mining | PubMed |
| A druggable copper-signalling pathway that drives inflammation. | Nature | 2023 | 37100912 | PubTator, text mining | PubMed |
| m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression. | Epigenetics | 2023 | 37092305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8846/papers?page=20